Karthick Vishwanathan, AstraZeneca

Karthick Vishwanathan is currently the interim head of the Clinical pharmacology and pharmacometrics group at AstraZeneca. He joined AZ in 2010 and progressively took on increased responsibilities to currently manage the CPQP groups across therapy areas and modalities.

Prior to joining AZ, Karthick received his B.Pharm. from Birla Institute of Technology and Sciences in India and his PhD in Pharmaceutical sciences from the University of Georgia (Athens, Georgia), USA in 2001. He has previously worked at Merck Research Labs and Wyeth Research prior to joining AZ. Karthick has worked on multiple drugs across early discovery to regulatory approval across the world that has made significant impact on patients’ lives. Karthick’s interest include developing drugs across modalities in multiple TA and continuously develop novel approaches that increase the success on the discovery and development of drugs. Outside of work, Karthick enjoys spending time with his family and loves to travel.